Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A concise primer comparing decentralization aspects of PoW and PoS, outlining key tradeoffs that impact security and resilience.
27,693 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Bitcoin slumped about 7% on Tuesday as U.S.-Iran tensions mounted, highlighting how macro risk can override crypto sa...
Bitcoin slides toward $60,000 raise fresh concerns for BLOK, the blockchain-focused ETF. This report explains potenti...
A soon-to-retire investor outlines a simple, income-centric ETF strategy built around three funds—JEPQ, DIVO, and SPH...
A high-potential niche in energy could unlock life-changing gains. Learn why small modular reactors and NuScale Power...
Global markets surged after President Trump hinted at de-escalation in Iran, easing oil risks and boosting equities. ...
As voters head toward the 2026 U.S. midterms, traders see a repeatable pattern: election-year volatility in stocks an...
U.S. lawmakers pledge rigorous oversight as the DOJ expands its probe into Binance’s sanctions compliance. The move s...
XRP has surged past BNB to claim the fourth-largest spot by market capitalization as Ripple unveils a Brazil expansio...
Tariff-Related Lawsuits Could Hurt Costco Stock Now examines how legal challenges tied to tariffs can affect a retail...
AI-driven cyber threats are accelerating, but the WisdomTree Cybersecurity Fund remains under pressure as its index c...
When top executives trim their holdings, investors pay attention. This article breaks down what a well timed trim mea...